Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Rheumatology

Symptoms and Warning Signs of Methotrexate Toxicity

At a Glance

The earliest signs of methotrexate toxicity often include painful mouth sores, unusual rashes, or severe fatigue. Serious warning signs requiring urgent medical care include unusual bruising, fever, shortness of breath, or accidentally taking a weekly dose on a daily schedule.

Methotrexate (MTX) affects how cells grow and divide. Because it targets fast-growing cells, it can sometimes cause side effects [1]. It is important to distinguish between mild, expected side effects (such as mild fatigue or slight nausea the day after taking a dose) and severe toxicity [2]. Early recognition of severe warning signs is essential for your safety.

Early Warning Signs in Low-Dose Therapy

For those taking low doses (typically once a week for rheumatology or dermatology), toxicity often appears first in the skin and mouth [2].

  • Oral Mucositis: Painful mouth sores or ulcers are often the very first sign of toxicity [2][3].
  • Skin Changes: Sudden facial swelling, a flat red rash (macular rash), or the sudden painful ulceration of existing psoriasis plaques [2][4].

URGENT ACTION: If you develop these painful mouth sores or unexplained rashes, stop taking methotrexate immediately and contact your doctor.

Dosing Errors: A Medical Emergency

Toxicity in low-dose patients is frequently caused by accidental daily dosing instead of the prescribed weekly schedule [5][6].
URGENT ACTION: If you realize you have taken methotrexate more frequently than prescribed (for example, two days in a row), do not take another dose and call your doctor or poison control immediately, even if you do not feel sick yet.

Signs of Bone Marrow Suppression

Methotrexate can cause myelosuppression, a condition where the bone marrow produces fewer blood cells than normal [7]. This can lead to pancytopenia, which is a severe drop in all three types of blood cells [8].

  • Low Platelets: Look for unusual bruising, bleeding gums, or small purple-red spots on the skin (petechiae) [8].
  • Low White Cells: This increases the risk of infection, which may present as a fever or chills [3].
  • Low Red Cells: This causes anemia, leading to extreme fatigue, weakness, or pale skin [7][8].

URGENT ACTION: If you experience fever, chills, unusual bruising, or bleeding gums, seek immediate medical care or go to the emergency room.

High-Dose Toxicity: Kidney and Brain

When used in high doses for cancer treatment, the risks and symptoms change. High-dose therapy requires intensive hospital monitoring [9].

Acute Kidney Injury (AKI)

High doses of methotrexate can form crystals inside the kidneys, leading to sudden kidney damage [10].

  • Symptoms: Decreased urine output (producing very little or no urine), swelling in the legs or ankles, and high blood pressure [10][11].
  • Monitoring: Doctors monitor serum creatinine (a waste product in the blood) and urine pH to ensure the kidneys are clearing the drug safely [9].

Neurotoxicity (Brain and Nerve Effects)

Methotrexate can sometimes affect the central nervous system, happening within days or even hours of treatment [12][13].

  • Encephalopathy: This presents as confusion, extreme sleepiness, or altered mental status [12].
  • Stroke-like Symptoms: Sudden weakness, difficulty speaking, or vision changes [14][15]. These symptoms require immediate medical evaluation.

Rare but Serious Lung Reaction

Methotrexate-induced pneumonitis is a rare, life-threatening lung inflammation that can occur at any dose [16]. It is a hypersensitivity reaction [17].

  • Warning Signs: A persistent dry cough, fever, and shortness of breath that worsens over a few days [16][17].
    URGENT ACTION: Stop taking the medication and go to the emergency room immediately if you experience severe shortness of breath or a sudden, persistent dry cough.

Critical Risk Factors

Certain factors significantly increase the risk of toxicity:

  • Have Kidney Issues: Any decrease in kidney function can cause the drug to build up to toxic levels [18][19].
  • Take Interacting Drugs: Medications like NSAIDs (e.g., ibuprofen) can interact with MTX [20]. Note: While NSAIDs are strictly forbidden during high-dose oncology therapy, rheumatology patients often take them safely with low-dose MTX under close medical supervision. Always check with your doctor, and ask if alternatives like acetaminophen (Tylenol) are safer for you.
  • Are Older: Patients over age 55 are at a higher risk for bone marrow suppression [6][21].

Common questions in this guide

What are the first signs of methotrexate toxicity?
Painful mouth sores or ulcers are often the very first sign of toxicity, especially in low-dose therapy. Sudden facial swelling or a flat red rash can also be early warning signs.
What should I do if I accidentally take my weekly methotrexate dose daily?
If you take methotrexate more frequently than prescribed, do not take another dose and call your doctor or poison control immediately. Accidental daily dosing is a medical emergency, even if you do not feel sick yet.
Why am I bruising so easily while taking methotrexate?
Methotrexate can suppress your bone marrow, leading to a dangerous drop in blood platelets. This increases your risk of unusual bruising, bleeding gums, or small purple-red spots on your skin, which require immediate medical attention.
Can methotrexate cause sudden lung problems or coughing?
Yes, a rare but life-threatening reaction called methotrexate-induced pneumonitis can occur at any dose. Warning signs include a persistent dry cough, fever, and shortness of breath that worsens over a few days.
Is it safe to take NSAIDs like ibuprofen with methotrexate?
NSAIDs like ibuprofen can interact with methotrexate and cause the drug to build up to toxic levels. While some rheumatology patients can use them safely under close supervision, you should always ask your doctor if they are safe for you.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I currently on a 'low-dose' or 'high-dose' regimen, and how does that change which symptoms I should watch for?
  2. 2.At what point should I stop my dose and call your office versus going straight to the emergency room?
  3. 3.If I accidentally take a daily dose instead of a weekly dose, what is the immediate first step I should take?
  4. 4.Is it safe for me to use over-the-counter pain relievers like acetaminophen (Tylenol) if I need to avoid NSAIDs?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    [Methotrexate osteopathy-a critical review].

    Braun J, Buehring B

    Zeitschrift fur Rheumatologie 2026; (85(3)):240-246 doi:10.1007/s00393-025-01755-4.

    PMID: 41324647
  2. 2

    Low-dose methotrexate toxicity leading to pancytopenia: leucovorin as a rescue treatment.

    Schelzel G, Palicherla A, Tauseef A, Millner P

    Proceedings (Baylor University. Medical Center) 2024; (37(2)):339-343 doi:10.1080/08998280.2023.2289299.

    PMID: 38343452
  3. 3

    Methotrexate-Induced Pancytopenia and Mucositis Caused by Medication Error.

    Amissah-Arthur MB, Baah W

    Ghana medical journal 2020; (54(1)):68-71 doi:10.4314/gmj.v54i1.10.

    PMID: 32863415
  4. 4

    From Treatment to Tragedy: Severe Methotrexate Toxicity With Mucocutaneous Ulcers, Myelosuppression, and Nephropathy.

    Sawant R, Chaudhari P, Bardiya NA, et al.

    Cureus 2024; (16(4)):e57797 doi:10.7759/cureus.57797.

    PMID: 38721177
  5. 5

    A Clinical Case of Methotrexate Toxicity.

    Peixoto AC, de Almeida Mota R, Rodrigues ALM, et al.

    Journal of medical cases 2025; (16(8)):314-317 doi:10.14740/jmc5159.

    PMID: 40904756
  6. 6

    Mucocutaneous Adverse Effects of Methotrexate Toxicity: A Case Series.

    Subedi B, Bhandari S, Timilsina S, et al.

    JNMA; journal of the Nepal Medical Association 2025; (63(283)):189-194 doi:10.31729/jnma.8905.

    PMID: 40656915
  7. 7

    A Rare Case of Acute Methotrexate Toxicity Leading to Bone Marrow Suppression.

    Khuwaja S, Lyons M, Zulfiqar B

    Case reports in rheumatology 2024; (2024()):7693602 doi:10.1155/2024/7693602.

    PMID: 38523896
  8. 8

    Hypoplastic Myelodysplastic Syndrome: Symptom of Methotrexate Toxicity in Rheumatoid Arthritis.

    Khan A, Anwar M, Azam A, et al.

    Cureus 2023; (15(6)):e40580 doi:10.7759/cureus.40580.

    PMID: 37469807
  9. 9

    Improving the safety of high-dose methotrexate for children with hematologic cancers in settings without access to MTX levels using extended hydration and additional leucovorin.

    Vaishnavi K, Bansal D, Trehan A, et al.

    Pediatric blood & cancer 2018; (65(12)):e27241 doi:10.1002/pbc.27241.

    PMID: 29768710
  10. 10

    [Methotrexate induced crystalline nephropathy: A rare histological finding on renal biopsy].

    Colpart P, Félix S

    Annales de pathologie 2019; (39(1)):18-23 doi:10.1016/j.annpat.2018.08.005.

    PMID: 30554834
  11. 11

    Crystalline Nephropathy With High-Dose Methotrexate in a Patient With Primary CNS Lymphoma: A Case Report.

    Sami FL, Hammo H, Athavale A

    Cureus 2022; (14(6)):e26052 doi:10.7759/cureus.26052.

    PMID: 35865443
  12. 12

    Role of molecular adsorbent recirculating system in methotrexate-induced acute liver failure: a case report and literature review.

    Corbisier T, Von Bueren AO, Breunis WB, Grazioli S

    Frontiers in pediatrics 2024; (12()):1424919 doi:10.3389/fped.2024.1424919.

    PMID: 39220154
  13. 13

    Prevalence and management of methotrexate-induced neurotoxicity in pediatric patients with osteosarcoma: a single-center experience.

    Peled Y, Levin D, Shiran S, et al.

    International journal of clinical oncology 2022; (27(8)):1372-1378 doi:10.1007/s10147-022-02184-y.

    PMID: 35639227
  14. 14

    Older age, CNS leukaemic involvement and induction tumour lysis increases the risk of methotrexate (MTX)-induced neurotoxicity in childhood acute lymphoblastic leukaemia/lymphoma: Experience from a tertiary care centre in South India.

    Rupakumar T, Sankar A, Vijayasekharan K, et al.

    British journal of haematology 2024; (205(1)):220-228 doi:10.1111/bjh.19559.

    PMID: 38797523
  15. 15

    Subacute methotrexate neurotoxicity in patients with oncohematological disease. A report of 3 cases.

    Delgado EF, Ruggeri RA, Calvo C

    Archivos argentinos de pediatria 2023; (121(2)):e202202649 doi:10.5546/aap.2022-02649.eng.

    PMID: 36378235
  16. 16

    The case of methotrexate and the lung: Dr Jekyll and Mr Hyde.

    Cottin V, Bendstrup E, Bonniaud P, et al.

    The European respiratory journal 2021; (57(2)) doi:10.1183/13993003.00079-2021.

    PMID: 33574052
  17. 17

    Low-dose methotrexate-induced acute interstitial pneumonitis: Report of two cases from South India and review of literature.

    Iyyadurai R, Carey RA, Satyendra S

    Journal of family medicine and primary care 2016; (5(4)):875-878 doi:10.4103/2249-4863.201163.

    PMID: 28349012
  18. 18

    Renal clearance and intracellular half-life essentially determine methotrexate toxicity: A case series.

    Arakawa Y, Arakawa A, Vural S, et al.

    JAAD case reports 2019; (5(1)):98-100 doi:10.1016/j.jdcr.2018.10.022.

    PMID: 30581945
  19. 19

    Severe bone marrow suppression due to methotrexate toxicity following aceclofenac-induced acute kidney injury.

    Manappallil RG, Prasan D, Peringat J, Biju IK

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2018-224722.

    PMID: 29871962
  20. 20

    Inhibition of Methotrexate Uptake via Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs.

    Iwaki M, Shimada H, Irino Y, et al.

    Biological & pharmaceutical bulletin 2017; (40(6)):926-931 doi:10.1248/bpb.b16-00970.

    PMID: 28566636
  21. 21

    Single Low-Dose Methotrexate and Vitamin B12 Deficiency-Induced Pancytopenia Causing Fatality: A Case Report.

    Akhdar G, Akpan I, Myles A, Atencah SE

    Cureus 2024; (16(6)):e63528 doi:10.7759/cureus.63528.

    PMID: 39081409

This page is for informational purposes only and does not replace professional medical advice. If you suspect methotrexate toxicity, experience severe symptoms, or accidentally took the wrong dose, seek emergency medical care or call poison control immediately.

Get notified when new evidence is published on Methotrexate toxicity.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.